Federated Hermes’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-14,305
Closed -$148K 2263
2020
Q1
$148K Buy
14,305
+1,408
+11% +$39.4K ﹤0.01% 1607
2019
Q4
$486K Sell
12,897
-1,881
-13% -$84.5K ﹤0.01% 1459
2019
Q3
$689K Sell
14,778
-622
-4% -$28.9K ﹤0.01% 1385
2019
Q2
$805K Sell
15,400
-457
-3% -$26.8K ﹤0.01% 1344
2019
Q1
$1.09M Buy
15,857
+375
+2% +$25.1K ﹤0.01% 1279
2018
Q4
$924K Sell
15,482
-801
-5% -$69.1K ﹤0.01% 1310
2018
Q3
$1.89M Sell
16,283
-601
-4% -$67.8K ﹤0.01% 1123
2018
Q2
$2.13M Sell
16,884
-279
-2% -$34K 0.01% 992
2018
Q1
$1.86M Sell
17,163
-383
-2% -$42.4K 0.01% 994
2017
Q4
$1.92M Sell
17,546
-3,501
-17% -$349K 0.01% 953
2017
Q3
$2.08M Buy
+21,047
New +$2.04M 0.01% 898
2016
Q3
Sell
-100,052
Closed -$12.4M 2125
2016
Q2
$12.4M Buy
+100,052
New +$12.1M 0.04% 379
2014
Q4
Sell
-319,730
Closed -$46.8M 1975
2014
Q3
$46.8M Buy
319,730
+56,900
+22% +$8.78M 0.15% 131
2014
Q2
$43.9M Buy
262,830
+46,330
+21% +$8.24M 0.14% 140
2014
Q1
$43M Buy
216,500
+58,100
+37% +$11M 0.14% 144
2013
Q4
$30.2M Buy
158,400
+59,260
+60% +$11M 0.1% 184
2013
Q3
$16.8M Buy
+99,140
New +$15.4M 0.06% 260

Other funds holding CLB

Federated Hermes's CLB Position: Q2 2020 in Review

Federated Hermes sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 14,305 shares — an estimated $148K sold.

Federated Hermes first reported a position in CLB in Q3 2013 and held it in 17 quarters. The position peaked at $46.8M in Q3 2014. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • Federated Hermes reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
  • Federated Hermes sold 14,305 Core Laboratories shares in Q2 2020, an estimated $148K.
  • Federated Hermes first reported a position in Core Laboratories in Q3 2013 and held it in 17 quarters.
  • Federated Hermes's Core Laboratories position peaked at $46.8M in Q3 2014.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.